New drug JSB462 tested for advanced prostate cancer in japanese patients
NCT ID NCT07174063
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests a new drug called JSB462 (Luxdegalutamide) in 15 Japanese men whose prostate cancer has spread to other parts of the body. The main goal is to check the drug's safety and how the body processes it. Participants take the drug once daily with food.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
JSB462 (Luxdegalutamide)
What this could lead to
If safe and effective, this drug could offer a new treatment option for Japanese men with advanced prostate cancer that has spread.
What could go wrong
This is a very early Phase 1 trial with only 15 participants, so it's too soon to know if the drug works. Side effects are unknown and could be serious.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC PROSTATE CANCER (MCRPC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Novartis Investigative Site
ACTIVE_NOT_RECRUITINGNagoya, Aichi-ken, 4668560, Japan
-
Novartis Investigative Site
ACTIVE_NOT_RECRUITINGKobe, Hyōgo, 650-0017, Japan
-
Novartis Investigative Site
RECRUITINGBunkyo Ku, Tokyo, 1138677, Japan
-
Novartis Investigative Site
RECRUITINGKoto Ku, Tokyo, 1358550, Japan